The question of whether the P. falciparum dynein heavy chain is a molecular target of peroxide-based antimalarials was addressed by showing it is covalently modified by a lipid peroxidation product, linking it to oxidative drug action.
Evidence Mass spectrometry identification of 4-HNE protein conjugates and adduct sites in plakortin-treated P. falciparum
- Single MS identification of a covalent adduct with no functional follow-up on the dynein heavy chain specifically
- Whether 4-HNE modification alters motor activity or contributes to drug killing is untested
- No structural or biochemical characterization of the protein accompanies the adduct mapping